EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Liraglutide-Driven Weight Loss Modulates Placental Remodeling in Obese Pregnancies in Mice

Natassia Rodrigo, Dunja Aksentijevic iD, Nikayla Patel iD, Carol A Pollock, Lana McClements, Sarah J Glastras iD

Cells · 2025

DOI: 10.3390/cells14242009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Natassia Rodrigo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes and Obesity Research Group, Kolling Institute of Medical Research, Sydney, NSW 2065, Australia. Hauptthemen laut MEDLINE: Liraglutide, Placenta, Weight Loss, Obesity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Juvenile Diabetes Research Foundation, JDRF Kickstart grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The placenta stands at the maternal–fetal interface and is a key organ regulating the intrauterine environment. In pregnancies exposed to obesity, placental function, signaling, and nutrient handling are adversely altered. Pre-conception weight loss is a potential intervention to alter an obesogenic milieu of pregnancy, which we investigated in a mouse model of maternal obesity using diet or administration of the glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide.

Methods

Pre-pregnancy weight loss in C57BL/6 high-fat diet (HFD)-fed dams was induced in the pre-pregnancy period by switching diet from HFD to chow diet or administering liraglutide (0.3 mg/kg/day subcutaneously for 4 weeks) whilst continuing HFD. In addition, a group of HFD-fed dams were switched to chow diet post-conception. The metabolomic profile and gene expression within the placenta was compared at day 18–20 of gestation.

Results

1H NMR spectroscopy metabolomic analysis of placenta of HFD mice showed an altered amino acid metabolomic profile, with lower aspartate, glutamate, and glutamine levels compared to the placenta of chow-fed mice (p < 0.05). Meanwhile, gene expression analysis identified both oxidative stress and inflammation in the placentas of HFD-fed dams. Whilst dietary modification alone was sufficient to reduce markers of oxidative stress and inflammation, liraglutide treatment modulated pathological changes, including placental metabolic stress but not inflammation.

Conclusions

These findings highlight the importance of dietary or pharmacological interventions in the pre- or immediate post-conception period, with pre-conception offering a critical window to reduce aberrant placental changes induced by obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiraglutidePlacentaWeight LossObesityPregnancy in ObesityAnimalsPregnancyFemaleMiceMice, Inbred C57BLDiet, High-FatOxidative Stress

Stichwörter der Autor:innen

dietliraglutideplacentapre-conceptionreproductive health

Substanzen

Liraglutide

Autor:innen und Institutionen

  • Diabetes and Obesity Research Group, Kolling Institute of Medical Research, Sydney, NSW 2065, Australia.
  • North Precinct, Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia.
  • Department of Diabetes, Endocrinology and Metabolism, Royal North Shore Hospital, Reserve Road, St Leonards, Sydney, NSW 2065, Australia.
  • Department of Diabetes and Endocrinology, Nepean Hospital, Sydney, NSW 2747, Australia.
  • William Harvey Research Institute, Barts and the London Faculty of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
  • School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, NSW 2007, Australia.

ORCID-Profile: Dunja Aksentijevic, Nikayla Patel, Sarah J Glastras

Förderung

  • Wellcome Trust
  • Juvenile Diabetes Research Foundation
  • JDRF Kickstart grant
  • Ramsey Research grant
  • Future Leader Fellowship Level 1 from the National Heart Foundation of Australia
  • Wellcome Trust Career Re-entry Fellowship
  • Barts Charity Grant
  • BHF MRes studentship

Zitieren

APA

Rodrigo, N., Aksentijevic, D., Patel, N., Pollock, C. A., McClements, L., & Glastras, S. J. (2025). Liraglutide-Driven Weight Loss Modulates Placental Remodeling in Obese Pregnancies in Mice. Cells. https://doi.org/10.3390/cells14242009

Vancouver

Rodrigo N, Aksentijevic D, Patel N, Pollock CA, McClements L, Glastras SJ. Liraglutide-Driven Weight Loss Modulates Placental Remodeling in Obese Pregnancies in Mice. Cells. 2025. doi:10.3390/cells14242009

BibTeX
@article{Rodrigo2025,
  author = {Rodrigo, Natassia and Aksentijevic, Dunja and Patel, Nikayla and Pollock, Carol A and McClements, Lana and Glastras, Sarah J},
  title = {Liraglutide-Driven Weight Loss Modulates Placental Remodeling in Obese Pregnancies in Mice},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14242009}
}
Kostenlos starten →